Effect of glucose-insulin-potassium in severe acute heart failure after brain death

Critical Care Medicine

Volumn 36, Issue 10, 2008, Pages 2740-2745

  Nicolas Robin, Armelle ^a   Amour, Julien ^a   Ibanez Esteve, Cristina ^a   Coriat, Pierre ^a   Riou, Bruno ^a   Langeron, Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brain death; Heart failure; Transplantation

Indexed keywords

DESMOPRESSIN; DIURETIC AGENT; DOBUTAMINE; GLUCOSE; INOTROPIC AGENT; INSULIN; NEUTRAL INSULIN; NORADRENALIN; POTASSIUM; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION;

ACUTE HEART FAILURE; BRAIN DEATH; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETES INSIPIDUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART RATE; HEART TRANSPLANTATION; HUMAN; INTENSIVE CARE UNIT; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MEAN ARTERIAL PRESSURE; ORGAN DONOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SCREENING TEST; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DONOR; DOPPLER ECHOCARDIOGRAPHY; DRUG COMBINATION; DRUG EFFECT; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; ORGAN PRESERVATION; PROBABILITY; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; BRAIN DEATH; CONFIDENCE INTERVALS; DOBUTAMINE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HEART FAILURE; HEART RATE; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; ORGAN PRESERVATION; POTASSIUM; PROBABILITY; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TISSUE DONORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 54549095054     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318186f64b     Document Type: Article

References (35)

1. Hunt SA, Abraham WT, Chin MH, et al: ACC/ AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235
2. Garrity ER, Moore J, Mulligan MS, et al: Heart and lung transplantation in the United States, 1996-2005. Am J Transplant 2007; 7:1390-1403
3. Punch JD, Hayes DH, LaPorte FB, et al: Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007; 7:1327-1338
4. Laks H, Marelli D, Fonarow GC, et al: Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg 2003; 125:49-59
5. Galinanes M, Hearse DJ: Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res 1992; 7:1213-1219
6. Kono T, Nishina T, Morita H, et al: Usefulness of low-dose dobutamine stress echocar-diography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999; 84:578-582
7. Schulz R, Rose J, Martin C, et al: Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and ino-tropic stimulation. Circulation 1993; 88: 684-695
8. Khoury VK, Haluska B, Prins J, et al: Effects of glucose-insulin- potassium infusion on chronic ischaemic left ventricular dysfunction. Heart 2003; 89:61-65
9. Taegtmeyer H, Goodwin GW, Doenst T, et al: Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80:3A-10A.
10. The CREATE-ECLA Trial Group Investigators: Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446
11. Preisman S, Kogan S, Berkenstadt H, et al: Predicting fluid responsiveness in patients undergoing cardiac surgery: Functional hae-modynamic parameters including the Respiratory Systolic Variation Test and static preload indicators. Br J Anaesth 2005; 95: 746-755
12. Magder S: Clinical usefulness of respiratory variations in arterial pressure. Am J Respir Crit Care Med 2004; 169:151-155
13. Guesde R, Barrou B, Leblanc I, et al: Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998; 352:1178-1181
14. Goarin JP, Cohen S, Riou B, et al: The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996; 83:41-47
15. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108
16. Urbanowicz JH, Shaaban MJ, Cohen NH, et al: Comparison of transesophageal echocar-diographic and scintigraphic estimates of left ventricular end-diastolic volume index and ejection fraction in patients following coronary artery bypass grafting. Anesthesiology 1990; 72:607-612
17. Konstadt SN, Thys D, Mindich BP, et al: Validation of quantitative intraoperative transesophageal echocardiography. Anesthesiology 1986; 65:418-421
18. Otterstad JE, Froeland G, St John Sutton M, et al: Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997; 18:507-513
19. Novitzky D, Rose AG, Cooper DK: Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon. Transplantation 1988; 45: 964-966
20. Riou B, Dreux S, Roche S, et al: Circulating cardiac troponin T in potential heart transplant donors. Circulation 1995; 92:409-414
21. Nicolas-Robin A, Salvi N, Medimagh S, et al: Combined measurements of N-terminal probrain natriuretic peptide and cardiac tro-ponins in potential organ donors. Intensive Care Med 2007; 33:986-992
22. Pilati CF, Bosso FJ, Maron MB: Factors involved in left ventricular dysfunction after massive sympathetic activation. Am J Physiol 1992; 263:H784-H791
23. Bolli R: Mechanism of myocardial stunning. Circulation 1990; 82:723-738
24. Szabo G, Buhmann V, Bahrle S, et al: Brain death impairs coronary endothelial function. Transplantation 2002; 73:1846-1848
25. Heusch G, Schulz R, Rahimtoola SH: Myocardial hibernation: A delicate balance. Am J Physiol 2005; 288:H984-H999
26. Schinkel AF, Bax JJ, Poldermans D: Clinical assessment of myocardial hibernation. Heart 2005; 91:111-117
27. Sodi-Pallares D, Testelli MR, Fishleder BL, et al: Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9:166-181
28. Goodwin GW, Taylor CS, Taegtmeyer H: Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998; 273:29530-29539
29. Korvald C, Elvenes OP, Myrmel T: Myocar-dial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 2000; 278:H1345- H1351
30. Stanley AW Jr, Moraski RE, Russell RO, et al: Effects of glucose-insulin-potassium on myo-cardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol 1975; 7:929-937
31. Alan S, Ulgen MS, Dedeoglu I, et al: Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy. Swiss Med Wkly 2003; 133:419-422
32. Cottin Y, Lhuillier I, Gilson L, et al: Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic car-diomyopathy. Eur J Heart Fail 2002; 4:181-184
33. Am J Cardiol 1982; 49:811-820
34. Robotham JL, Takata M, Berman M, et al: Ejection fraction revisited. Anesthesiology 1991; 74:172-183
35. Folland ED, Parisi AF, Moynihan PF, et al: Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 1979; 60:760-766